{"name":"Gemma Biotherapeutics","slug":"gemma-biotherapeutics","ticker":"","exchange":"","domain":"gemmabiotherapeutics.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PBGM01","genericName":"PBGM01","slug":"pbgm01","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"PBGM01","genericName":"PBGM01","slug":"pbgm01","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFBESDF1NGVCZi1Ia2F3bm9maUl2SUpDUHFDWXU0YlNrRHpPckw4SF9OSmNEeVpFWHFlMFVCc21ITHNtTjBLSy02elp1SnE2SGNORFdEWDA3WVVaNndPaU55RmhORjFRd0UyTXRlMmZ3QjNYT0dXSVJ5eXNCZ2JieE0?oc=5","date":"2025-10-08","type":"pipeline","source":"The Pharma Letter","summary":"GEMMABio launches new company - The Pharma Letter","headline":"GEMMABio launches new company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxPWGI2SkViWk9PbjhGZ081S0J3RU80bDRHM2t6QkJFZ0tWSm1CYUVFeWM4bWUyZnQxb1NzcXJJWEU5aldLbWs4c3dvVmJXeC01TGJWU0l6M1BjV3dOOHdsd2Z0ZXoxYW8tckwtd2JEV2RmRzI0dF9ucUR6NXJLWE1wOWtjd2d2akQ0Z3MzaDZROGk3WGtfS0xXYTBRWEI5V242R1M3NFppaC1XQmpiZm5QOHhhckY5UldkU25pUE1aUHJnTGpBX2pOQ29lTFFCcTB6bWVlY256RHRJU0h3YzZoNG5LNG5HaUNtak1OWjJJNA?oc=5","date":"2025-10-07","type":"pipeline","source":"PR Newswire","summary":"GEMMABio Launches Rare Therapeutics, Inc. to Develop and Deliver Gene Therapies for Ultra‑Orphan Diseases - PR Newswire","headline":"GEMMABio Launches Rare Therapeutics, Inc. to Develop and Deliver Gene Therapies for Ultra‑Orphan Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPUkxqZlNlQkxnbTB4VnNDUTcxV0NSY0NJeDcwdk1MZFNwcWhMV3lQQVE0dWxGVENhZFJobnpVWFkzN0xoUzdZTGJleWYyUElIei1OTFhjc05pellsTFVkQXBqaUVlRnhUd2hKVmdBU2lhNWhXaVJ0UHd4VjBWcW9iNWE1ZlpMdXVzWFNCbzZrNG1JQm9JYnc4b29nRjlyRkFtVGpwamxDMlFyODZUdDRKbjZvMjRYNXM?oc=5","date":"2025-10-07","type":"pipeline","source":"Fierce Biotech","summary":"James Wilson's GEMMABio launches new gene therapy biotech for 'ultra-orphan' diseases - Fierce Biotech","headline":"James Wilson's GEMMABio launches new gene therapy biotech for 'ultra-orphan' diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxOM2lWd3Rkc2Nkb0U4SlBfUW9BRVpRSDFWUkZrd0tDUzNpWnFXZGdYOE9GY1gtOFVMSDJPbEQ0Zm5sbkw1dFkzcjB1aDRiQWlzZ2NDeEloWmlHLW9MeWdBaFluVnhmSFdBazdnZzcxTzRzc1RRYk51MGFBdHZLOEtSLTVvTXVxeEwyRGxpTW5fZFFXRklUUnFmTFBORm9iZ3A3Vmpic09FVmVVSVo4VXg5azRXSk1hWGw5a1BLaGZvYlpqLVZDTzVOcnBwSGJQcU5Z?oc=5","date":"2025-08-21","type":"pipeline","source":"BioBuzz","summary":"The Rise of the CAR-T Corridor: How Philadelphia and Maryland Are Shaping the Future of Cell Therapy - BioBuzz","headline":"The Rise of the CAR-T Corridor: How Philadelphia and Maryland Are Shaping the Future of Cell Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE41WEc3MlR0aElQWFpEQlkzY3MyVnN3M3dvYlRlR2ltaElzUVpRQkZja0lUN0hxZ2t1STdlaHBROWREYTN3bGRyalo4SFE5RTB4bURsTUtQMHJCRld3ZjEtcGJDcThSLWZUellaZWZOQzFvWU0?oc=5","date":"2025-04-28","type":"regulatory","source":"CHEManager","summary":"Gemma Biotherapeutics - CHEManager","headline":"Gemma Biotherapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQVWxoSGoxOGtHNjBjLWFIZzVjN3ZTcmVWT3FHYzFrQ1oxcllhYmpWM2tUQzRsUlpiblYwcTFPcEN4a3NGbTVtcEk1Y1pOVFc5TXlVZmFWaWtHWHJQSUFpYy1YNDhmT283bmRyLUxDaTMyZ1lfMEl4a2psWGxXQW1vcFBwc2xRQkZ4UlJiaHZLMW90UmZjV3c?oc=5","date":"2025-01-09","type":"pipeline","source":"Contract Pharma","summary":"GEMMA Biotherapeutics Names May Orfali as CMO - Contract Pharma","headline":"GEMMA Biotherapeutics Names May Orfali as CMO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNV2Q3MVhHRlpJbHdrWG5ITHJhbGZUaGg0Ti1DZXVIWmhQVWM5N1VsemZjWS1VNGdPTllxQko1TXgtRVlvbGMxcVRfRllTaG5mdnlOWmJNcERnR3oyLV9tdENjUmdfbXVLUHgydG8yaU1pRWRZTkE4NnlobC1OdnB1TXZLQ2VndVFlYmRfcGxsMi1FbGdIcWwzX2tQNEU?oc=5","date":"2024-12-24","type":"pipeline","source":"C&EN","summary":"Jim Wilson’s latest gene therapy start-up raises $34 million - C&EN","headline":"Jim Wilson’s latest gene therapy start-up raises $34 million - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOV054R0wzc04wRjdabUt6Y3lhbDQ0ZWdBVXg3WmR6UEE0WjBoRlVtWV96LUEya0VzLXZ3RFN0V1pDa0xyTmJxNUlsZmxwa1FuYXk0aTJKejczZktWSGlVemEtTXVXSlJJVHNyUEcxZmZvMnNEdFFobUswdXZ3NFBHTThTLW82RGdnUEhwdkdKQi1KalFGMzFmblJvUUFuV1V2eG1HMUVDOVlGLWhpcTZHWlczMkMwZw?oc=5","date":"2024-08-22","type":"pipeline","source":"statnews.com","summary":"Gene therapy pioneer Jim Wilson believes he can commercialize rare-disease drugs in a tough climate - statnews.com","headline":"Gene therapy pioneer Jim Wilson believes he can commercialize rare-disease drugs in a tough climate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOcWprM3RMOFl1N1QwQWxrVFh3bHA3QWl2eHIxRnpkUzFPbkQ1dW1vcWNTMHdURXpkRGd5dFNfaU1oVHpXOENuMWE1bjZvZGtHdC12TWF2TU9sRm4yUFd2c0ROdjR4Ync2OHhkS09rRzJzYnRpZnM1eHk5ZEFpS3MtV3BIUXdPN3JOU0hvSTdGbllrZnRVejA5bUdSV2xOY2ZFSmtZZFdkRGtiQQ?oc=5","date":"2024-08-02","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Takeda taps internal leader as head of US oncology business - Fierce Biotech","headline":"Chutes & Ladders—Takeda taps internal leader as head of US oncology business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOWEJPODNVZm5hbEhNdmU5akoyNzZpTzNMWjh1OWFaS3dINGMxVV9WeHZHSXZUaktpZnpDV2dBZjdZZmU2R2xxcHUtWUFDbEljcnhDc2ZLd3lyczdCSEF2RkxlWmNnUE1OaEI5aS1QcnJNR0ZJNmRpN2xMU0hSeUJHMllPaGUxRTNnNFlQOUw4cUhaOURVa0NmZ1JxRS1ocElXbFRicnV4RzNodw?oc=5","date":"2024-08-01","type":"pipeline","source":"BioPharma Dive","summary":"Jim Wilson, prominent gene therapy researcher, to depart UPenn - BioPharma Dive","headline":"Jim Wilson, prominent gene therapy researcher, to depart UPenn","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}